Molecular diagnostic company
FDA draft guidance to regulate laboratory developed tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and FDA. PL 113-93 (HR 4302) - Protecting Access to Medicare Act of 2014; implementation of changes to Medicare payment for clinical laboratory tests.
MED - Medical/Disease Research/Clinical Labs MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FAEGRE BAKER DANIELS CONSULTING
1050 K Street NW, Suite 400, Washington, DC, 20001, US
JOHN KEVIN BRENNAN JOHN KEVIN BRENNAN